Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
Weekly gemcitabine and 24-hour infusional 5-fluorouracil in advanced pancreatic cancer: a phase I-II study.
See All Pages
Find People
Find Everything
Login
to
edit your profile
(add a photo, education, awards, etc.), search
student opportunities
, and
create reports
.
Edit My Profile
My Person List (
0
)
Opportunity Search
Return to Top
Weekly gemcitabine and 24-hour infusional 5-fluorouracil in advanced pancreatic cancer: a phase I-II study.
Weekly gemcitabine and 24-hour infusional 5-fluorouracil in advanced pancreatic cancer: a phase I-II study. Oncology. 2003; 64(2):139-45.
View in:
PubMed
subject areas
Adult
Aged
Antimetabolites, Antineoplastic
Antineoplastic Combined Chemotherapy Protocols
Deoxycytidine
Drug Administration Schedule
Female
Fluorouracil
Humans
Male
Middle Aged
Neoplasm Staging
Pancreatic Neoplasms
Survival Analysis
Treatment Outcome